News Reduction of share capital Staff April 20, 2022 Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Post Navigation Previous Clover’s Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious DiseaseNext Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss More Stories News CorVel Announces Effectiveness of Three-For-One Forward Stock Split Staff December 25, 2024 Cancer Clinical Trial DNA Melanoma News Pharmaceutical Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca Staff December 25, 2024 Fitness Healthcare Mental Health News Nutrition Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025 Staff December 24, 2024
